Extract financial metrics from a synthetic 10-K packet, write the resulting table as CSV or JSONL, then validate the generated artifact with a deterministic eval script. The packet uses synthetic ...

// Licensed under the Apache License, Version 2.0 (the "License"); // you may not use this file except in compliance with the License. // You may obtain a copy of the ...

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion, in another indication of the Australian company’s financial distress since its ill-fated 2022 ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

From blue-chip royalty to bin fire, the company’s staggering fall is a brutal reckoning for the Australian icon lost in its own complacency and hubris. Logic tells us worrying about round numbers in ...

In a 90-day review, CSL told the market it would take another $US5bn ($A6.9bn) non-cash impairment. The first $1.5bn of this was recognised during the first-half ...

Two weeks before he announced CSL’s latest shock earnings downgrade, Gordon Naylor was scheduled to sit down with investors in Melbourne to brief them on the healthcare giant’s financial performance.

Japan’s medicines regulator has approved the first vaccine based on self-assembling RNA, a spin on the mRNA technology used in current shots, which is designed to deliver greater efficacy with a lower ...

Biotechnology business CSL, which specialises in bloods, vaccines and plasma products, flagged a US$5 billion (AU$6.9 billion) write-down of its assets. The Melbourne-headquartered company also ...

There is no longer any pretending that US President Donald Trump and his vaccine-sceptic health secretary, Robert F. Kennedy Jr, are solely to blame for the massive destruction of wealth for investors ...